Targeted Blue Nanoparticles as Photoacoustic Contrast Agent for Brain Tumor Delineation

Area of Science:

• Biomedical Engineering
• Surgical Oncology
• Medical Imaging

Background:

• Distinguishing tumors from healthy tissue during surgery is difficult.
• Current methods using visible or fluorescent agents have limitations.
• Novel imaging techniques are needed to improve intraoperative tumor delineation.

Purpose of the Study:

• To develop and evaluate a novel photoacoustic imaging (PAI) technique for brain tumor delineation.
• To utilize tumor-targeting blue nanoparticles as a contrast agent for enhanced PAI sensitivity.
• To assess the potential of this method for improving intraoperative surgical guidance.

Main Methods:

• Photoacoustic imaging technique utilizing blue nanoparticles as a contrast agent.
• Experiments conducted on phantoms and ex vivo rat brains.
• Determination of the limit of detection for the nanoparticles.

Main Results:

• PAI demonstrated high sensitivity in delineating tumors containing blue nanoparticles.
• Tumor visualization was achieved at concentrations significantly lower than naked-eye detection.
• The limit of detection for nanoparticles was found to be approximately 0.77 μg/mL.

Conclusions:

• Photoacoustic imaging with blue nanoparticles offers a highly sensitive method for intraoperative tumor delineation.
• This approach can reveal tumor distribution and extent, potentially improving surgical outcomes.
• The technique shows promise for enhancing cancer surgery by providing real-time visualization of tumor margins.